These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23960739)

  • 1. Anti-inflammatory activity of telmisartan in rat models of experimentally-induced chronic inflammation: Comparative study with dexamethasone.
    Al-Hejjaj WK; Numan IT; Al-Sa'ad RZ; Hussain SA
    Saudi Pharm J; 2011 Jan; 19(1):29-34. PubMed ID: 23960739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ameliorative effects of telmisartan on the inflammatory response and impaired spatial memory in a rat model of Alzheimer's disease incorporating additional cerebrovascular disease factors.
    Shindo T; Takasaki K; Uchida K; Onimura R; Kubota K; Uchida N; Irie K; Katsurabayashi S; Mishima K; Nishimura R; Fujiwara M; Iwasaki K
    Biol Pharm Bull; 2012; 35(12):2141-7. PubMed ID: 23207766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor necrosis factor-alpha-induced interleukin-6 expression by telmisartan through cross-talk of peroxisome proliferator-activated receptor-gamma with nuclear factor kappaB and CCAAT/enhancer-binding protein-beta.
    Tian Q; Miyazaki R; Ichiki T; Imayama I; Inanaga K; Ohtsubo H; Yano K; Takeda K; Sunagawa K
    Hypertension; 2009 May; 53(5):798-804. PubMed ID: 19289654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection.
    Attia YM; Elalkamy EF; Hammam OA; Mahmoud SS; El-Khatib AS
    Parasit Vectors; 2013 Jul; 6():199. PubMed ID: 23829789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan attenuates peritoneal fibrosis via peroxisome proliferator-activated receptor-γ activation in rats.
    Su X; Yu R; Yang X; Zhou G; Wang Y; Li L; Li D
    Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):671-9. PubMed ID: 25867712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telmisartan inhibits vascular dysfunction and inflammation via activation of peroxisome proliferator-activated receptor-γ in subtotal nephrectomized rat.
    Toba H; Tojo C; Wang J; Noda K; Kobara M; Nakata T
    Eur J Pharmacol; 2012 Jun; 685(1-3):91-8. PubMed ID: 22314223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin potentiates the anti-inflammatory activity of cyclooxygenase inhibitors in the cotton pellet granuloma pouch model.
    Nandal S; Dhir A; Kuhad A; Sharma S; Chopra K
    Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):89-93. PubMed ID: 19455263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytes.
    Pang T; Benicky J; Wang J; Orecna M; Sanchez-Lemus E; Saavedra JM
    J Hypertens; 2012 Jan; 30(1):87-96. PubMed ID: 22124178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroprotective effects of telmisartan on experimentally-induced gastric ulcers in rats.
    Morsy M; Ashour O; Amin E; Rofaeil R
    Pharmazie; 2009 Sep; 64(9):590-4. PubMed ID: 19827301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan ameliorates Aβ oligomer-induced inflammation via PPARγ/PTEN pathway in BV2 microglial cells.
    Wang ZF; Li J; Ma C; Huang C; Li ZQ
    Biochem Pharmacol; 2020 Jan; 171():113674. PubMed ID: 31634455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.
    Nenicu A; Körbel C; Gu Y; Menger MD; Laschke MW
    Hum Reprod; 2014 May; 29(5):1011-24. PubMed ID: 24578472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan directly ameliorates the neuronal inflammatory response to IL-1β partly through the JNK/c-Jun and NADPH oxidase pathways.
    Pang T; Wang J; Benicky J; Sánchez-Lemus E; Saavedra JM
    J Neuroinflammation; 2012 May; 9():102. PubMed ID: 22642771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan promotes potential glucose homeostasis in stroke-resistant spontaneously hypertensive rats via peroxisome proliferator-activated receptor γ activation.
    Omote Y; Deguchi K; Kurata T; Yamashita T; Sato K; Hishikawa N; Abe K
    Curr Neurovasc Res; 2015; 12(1):91-7. PubMed ID: 25557372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telmisartan, a partial agonist of peroxisome proliferator-activated receptor gamma, improves impairment of spatial memory and hippocampal apoptosis in rats treated with repeated cerebral ischemia.
    Haraguchi T; Iwasaki K; Takasaki K; Uchida K; Naito T; Nogami A; Kubota K; Shindo T; Uchida N; Katsurabayashi S; Mishima K; Nishimura R; Fujiwara M
    Brain Res; 2010 Sep; 1353():125-32. PubMed ID: 20637184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan protects against vascular dysfunction with peroxisome proliferator-activated receptor-γ activation in hypertensive 5/6 nephrectomized rats.
    Toba H; Wang J; Ohigashi M; Kobara M; Nakata T
    Pharmacology; 2013; 92(5-6):265-75. PubMed ID: 24281041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective effects of azilsartan compared with that of telmisartan on an in vivo model of myocardial ischemia-reperfusion injury.
    Garg S; Khan SI; Malhotra RK; Sharma MK; Kumar M; Kaur P; Nag TC; Ray R; Bhatia J; Arya DS
    J Biochem Mol Toxicol; 2021 Jul; 35(7):e22785. PubMed ID: 33860986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway.
    Li H; Lu W; Cai WW; Wang PJ; Zhang N; Yu CP; Wang DL; Liu BC; Sun W
    Pulm Pharmacol Ther; 2014 Jun; 28(1):17-24. PubMed ID: 24269521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.
    Garrido-Gil P; Joglar B; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    J Neuroinflammation; 2012 Feb; 9():38. PubMed ID: 22356806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
    Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
    Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan inhibits cytokine-induced nuclear factor-kappaB activation independently of the peroxisome proliferator-activated receptor-gamma.
    Nakano A; Hattori Y; Aoki C; Jojima T; Kasai K
    Hypertens Res; 2009 Sep; 32(9):765-9. PubMed ID: 19590508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.